Zoltan Sutto
Datos Biográficos
| ID | 9018928 |
|---|---|
| NOMBRE | Zoltan Sutto |
| NOMBRES | Zoltan |
| APELLIDO | Sutto |
| FIRMA | SUTTO Z |
| AFILIACIONES | Semmelweis University |
| ORCID | 0000-0002-6871-0901 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| OBRAS COMO AUTOR | 1 |
| OBRAS COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2022 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2022 |
| ÍNDICE H | 0 |
Long-term survival benefit of male and multimorbid Covid-19 patients with 5-day remdesivir treatment
Background: Treatment of the coronavirus disease (COVID-19) is still challenging due to the lack of evidence-based treatment protocols and continuously changing epidemiological situations and vaccinations. Remdesivir (RDV) is among the few antiviral medications with confirmed efficacy for specific patient groups. However, real-world data on long-term outcomes for a short treatment course are scarce. Methods: This retrospective observational cohor…
Sin obras prominentes en esta página.
Long-term survival benefit of male and multimorbid Covid-19 patients with 5-day remdesivir treatment
Background: Treatment of the coronavirus disease (COVID-19) is still challenging due to the lack of evidence-based treatment protocols and continuously changing epidemiological situations and vaccinations. Remdesivir (RDV) is among the few antiviral medications with confirmed efficacy for specific patient groups. However, real-world data on long-term outcomes for a short treatment course are scarce. Methods: This retrospective observational cohor…
Cohort study (1 obra) · Comorbidity (1 obra) · COPD (1 obra) · COVID-19 Clinical Research Studies (1 obra) · Diabetes mellitus (1 obra) · Epidemiology (1 obra) · Internal Medicine (1 obra) · Medicine (1 obra) · Pharmacological Receptor Mechanisms and Effects (1 obra) · Propensity score matching (1 obra)